Peng Shu Selected Research

Peng Shu Research Topics

Disease

25	Neoplasms (Cancer) 04/2024 - 06/2016
11	Stomach Neoplasms (Stomach Cancer) 04/2024 - 11/2019
7	Infections 02/2024 - 12/2015
5	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
3	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2018
3	Multiple Myeloma 01/2020 - 04/2019
2	Wounds and Injuries (Trauma) 05/2024 - 01/2020
2	Inflammation (Inflammations) 04/2024 - 06/2016
2	Venous Thromboembolism 10/2023 - 01/2023
2	Carcinogenesis 08/2022 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 06/2016
2	Hypoxia (Hypoxemia) 10/2019 - 01/2019
1	Diabetic Foot 05/2024
1	Ulcer 05/2024
1	Disease Progression 12/2023
1	Osteosarcoma (Osteogenic Sarcoma) 12/2023
1	Body Weight (Weight, Body) 11/2023
1	Atopic Dermatitis (Atopic Eczema) 11/2023
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023
1	Pulmonary Embolism 01/2023
1	Hyperuricemia 01/2023
1	Endometrial Neoplasms (Endometrial Cancer) 01/2023
1	Disease Resistance 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Male Infertility (Male Sterility) 01/2023
1	Spondylolisthesis 10/2022
1	Pain (Aches) 10/2022
1	Low Back Pain (Lumbago) 10/2022
1	Lordosis 10/2022
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2022
1	Ischemic Stroke 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Cholangiocarcinoma 01/2022
1	Necrosis 12/2021
1	Osteonecrosis (Kienbock's Disease) 12/2021
1	COVID-19 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 10/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2020
1	Paresthesia (Dysesthesia) 05/2020

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2018
8	Messenger RNA (mRNA)IBA 12/2023 - 10/2018
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2019
5	MicroRNAs (MicroRNA)IBA 05/2019 - 06/2016
3	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2019
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2020 - 10/2019
2	CytokinesIBA 05/2024 - 04/2017
2	kaempferolIBA 04/2024 - 03/2024
2	Uric Acid (Urate)IBA 10/2023 - 01/2023
2	Carrier Proteins (Binding Protein)IBA 01/2023 - 01/2020
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2023 - 01/2020
2	Therapeutic UsesIBA 01/2021 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 11/2020 - 06/2020
2	CateninsIBA 10/2019 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 11/2018 - 06/2016
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018 - 08/2017
1	SolutionsIBA 05/2024
1	ArbutinIBA 04/2024
1	FlavonoidsIBA 04/2024
1	QuercetinIBA 03/2024
1	alpha-Linolenic Acid (Linolenic Acid)IBA 03/2024
1	ethyleneIBA 02/2024
1	baicaleinIBA 01/2024
1	baicalinIBA 01/2024
1	Circular RNAIBA 12/2023
1	RetinoidsIBA 11/2023
1	Cisplatin (Platino)FDA LinkGeneric 11/2023
1	DinitrofluorobenzeneIBA 11/2023
1	calloseIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2023
1	Hemoglobins (Hemoglobin)IBA 10/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2022
1	AgarIBA 08/2022
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 08/2022
1	Epidermal Growth Factor (EGF)IBA 05/2022
1	P-2 (P 2)IBA 01/2022
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	CXC ChemokinesIBA 01/2022
1	GlypicansIBA 01/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	SteroidsIBA 12/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	DiosgeninIBA 01/2021
1	7,3'-dihydroxy-4'-methoxyisoflavoneIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 07/2020
1	ErbB Receptors (EGF Receptor)IBA 07/2020
1	Tumor Biomarkers (Tumor Markers)IBA 06/2020
1	Flap EndonucleasesIBA 06/2020

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 11/2023 - 10/2019
6	Therapeutics 01/2023 - 12/2018
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 11/2019
3	Immunotherapy 01/2023 - 01/2021
1	X-Ray Film 10/2022
1	Internal Fixators 10/2022
1	Adjuvant Chemotherapy 01/2022
1	Transplantation 12/2021
1	Integrative Oncology 01/2021